Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
申请人:Jones M. Robert
公开号:US20070078150A1
公开(公告)日:2007-04-05
The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism.
Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity.
SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO
申请人:Arena Pharmaceuticals, Inc.
公开号:EP1732562B1
公开(公告)日:2007-12-19
US8362248B2
申请人:——
公开号:US8362248B2
公开(公告)日:2013-01-29
[EN] SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO<br/>[FR] DERIVES DE PYRIDINYLE ET DE PYRIMIDINYLE SUBSTITUES EN TANT QUE MODULATEURS DU METABOLISME ET TRAITEMENT DE TROUBLES ASSOCIES
申请人:ARENA PHARM INC
公开号:WO2006083491A2
公开(公告)日:2006-08-10
[EN] The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic- related disorders and complications thereof, such as, diabetes and obesity. [FR] La présente invention concerne certains dérivés de pyridinyle et de pyrimidinyle substitués de formule (Ia) qui sont des modulateurs du métabolisme. Ainsi, les composés de la présente invention sont utiles dans le traitement de troubles liés au métabolisme et de leurs complications, notamment du diabète et de l'obésité.
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
申请人:Jones M. Robert
公开号:US20060155128A1
公开(公告)日:2006-07-13
The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism.
Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity.